ArticleLaboratory investigation; a journal of technical methods and pathology2022

MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis.

Yongfeng Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.